Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Can we make human plague history? A call to action.

Baril L, Vallès X, Stenseth NC, Rajerison M, Ratsitorahina M, Pizarro-Cerdá J, Demeure C, Belmain S, Scholz H, Girod R, Hinnebusch J, Vigan-Womas I, Bertherat E, Fontanet A, Yazadanpanah Y, Carrara G, Deuve J, D'ortenzio E, Angulo JOC, Mead P, Horby PW.

BMJ Glob Health. 2019 Nov 10;4(6):e001984. doi: 10.1136/bmjgh-2019-001984. eCollection 2019. No abstract available.

2.

Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination and diagnostics.

Demeure C, Dussurget O, Fiol GM, Le Guern AS, Savin C, Pizarro-Cerdá J.

Microbes Infect. 2019 Jun - Jul;21(5-6):202-212. doi: 10.1016/j.micinf.2019.06.007. Epub 2019 Jun 25.

3.

Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.

Demeure CE, Dussurget O, Mas Fiol G, Le Guern AS, Savin C, Pizarro-Cerdá J.

Genes Immun. 2019 May;20(5):357-370. doi: 10.1038/s41435-019-0065-0. Epub 2019 Apr 3. Review.

4.

Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.

Demeure CE, Derbise A, Guillas C, Gerke C, Cauchemez S, Carniel E, Pizarro-Cerdá J.

Vaccine. 2019 Jan 3;37(1):123-129. doi: 10.1016/j.vaccine.2018.11.022. Epub 2018 Nov 19.

5.

Enhanced Macrophage M1 Polarization and Resistance to Apoptosis Enable Resistance to Plague.

Pachulec E, Abdelwahed Bagga RB, Chevallier L, O'Donnell H, Guillas C, Jaubert J, Montagutelli X, Carniel E, Demeure CE.

J Infect Dis. 2017 Sep 15;216(6):761-770. doi: 10.1093/infdis/jix348.

PMID:
28934426
6.

Oral vaccination against plague using Yersinia pseudotuberculosis.

Demeure CE, Derbise A, Carniel E.

Chem Biol Interact. 2017 Apr 1;267:89-95. doi: 10.1016/j.cbi.2016.03.030. Epub 2016 Apr 1.

7.

Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.

Derbise A, Hanada Y, Khalifé M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004162. doi: 10.1371/journal.pntd.0004162. eCollection 2015.

8.

Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci.

Simon S, Demeure C, Lamourette P, Filali S, Plaisance M, Créminon C, Volland H, Carniel E.

PLoS One. 2013;8(1):e54947. doi: 10.1371/journal.pone.0054947. Epub 2013 Jan 29.

9.

Resistance to plague of Mus spretus SEG/Pas mice requires the combined action of at least four genetic factors.

Chevallier L, Blanchet C, Jaubert J, Pachulec E, Demeure C, Carniel E, Panthier JJ, Montagutelli X.

Genes Immun. 2013 Jan;14(1):35-41. doi: 10.1038/gene.2012.50. Epub 2012 Nov 15.

PMID:
23151488
10.

An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.

Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2012;6(2):e1528. doi: 10.1371/journal.pntd.0001528. Epub 2012 Feb 14.

11.

Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice.

Demeure CE, Blanchet C, Fitting C, Fayolle C, Khun H, Szatanik M, Milon G, Panthier JJ, Jaubert J, Montagutelli X, Huerre M, Cavaillon JM, Carniel E.

J Infect Dis. 2012 Jan 1;205(1):134-43. doi: 10.1093/infdis/jir696. Epub 2011 Nov 16.

12.

Delineation and analysis of chromosomal regions specifying Yersinia pestis.

Derbise A, Chenal-Francisque V, Huon C, Fayolle C, Demeure CE, Chane-Woon-Ming B, Médigue C, Hinnebusch BJ, Carniel E.

Infect Immun. 2010 Sep;78(9):3930-41. doi: 10.1128/IAI.00281-10. Epub 2010 Jul 6.

13.

Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis.

Quintard B, Petit T, Ruvoen N, Carniel E, Demeure CE.

Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e59-65. doi: 10.1016/j.cimid.2009.12.001. Epub 2010 Jan 19.

14.

Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

Blisnick T, Ave P, Huerre M, Carniel E, Demeure CE.

Infect Immun. 2008 Aug;76(8):3808-16. doi: 10.1128/IAI.00034-08. Epub 2008 May 27.

15.

Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia.

Demeure CE, Brahimi K, Hacini F, Marchand F, Péronet R, Huerre M, St-Mezard P, Nicolas JF, Brey P, Delespesse G, Mécheri S.

J Immunol. 2005 Apr 1;174(7):3932-40.

16.

Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo.

Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, Boudaly S, Mécheri S.

J Immunol. 2003 Mar 15;170(6):3037-45.

17.
18.

Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation.

Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, Brown EJ, Maliszewski C, Lindberg FP, Oldenborg A, Ullrich A, Delespesse G, Sarfati M.

J Immunol. 2001 Sep 1;167(5):2547-54.

20.

CD47 engagement inhibits cytokine production and maturation of human dendritic cells.

Demeure CE, Tanaka H, Mateo V, Rubio M, Delespesse G, Sarfati M.

J Immunol. 2000 Feb 15;164(4):2193-9.

21.

OX40-Mediated cosignal enhances the maturation of naive human CD4+ T cells into high IL-4-producing effectors.

Delespesse G, Ohshima Y, Yang LP, Demeure C, Sarfati M.

Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):384-6.

PMID:
10224454
22.

Naive human CD4+ T cells are a major source of lymphotoxin alpha.

Ohshima Y, Yang LP, Avice MN, Kurimoto M, Nakajima T, Sergerie M, Demeure CE, Sarfati M, Delespesse G.

J Immunol. 1999 Apr 1;162(7):3790-4.

23.
25.

Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors.

Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG, Sarfati M.

Vaccine. 1998 Aug-Sep;16(14-15):1415-9. Review.

PMID:
9711781
26.

Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines.

Demeure CE, Yang LP, Desjardins C, Raynauld P, Delespesse G.

Eur J Immunol. 1997 Dec;27(12):3526-31.

PMID:
9464843
27.

In vitro maturation of naive human CD4+ T lymphocytes into Th1, Th2 effectors.

Delespesse G, Demeure CE, Yang LP, Ohshima Y, Byun DG, Shu U.

Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):157-9. Review. No abstract available.

PMID:
9130509
28.

Human Th2-like cell clones induce IL-12 production by dendritic cells and may express several cytokine profiles.

Vezzio N, Sarfati M, Yang LP, Demeure CE, Delespesse G.

Int Immunol. 1996 Dec;8(12):1963-70.

PMID:
8982781
29.

Role of interleukin-12 in the maturation of naive human CD4 T cells.

Delespesse G, Yang LP, Shu U, Byun DG, Demeure CE, Ohshima Y, Wu CY, Sarfati M.

Ann N Y Acad Sci. 1996 Oct 31;795:196-201. No abstract available.

PMID:
8958930
30.

CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells.

Demeure CE, Byun DG, Yang LP, Vezzio N, Delespesse G.

Immunology. 1996 May;88(1):110-5.

31.

Maturation of neonatal human CD4 T cells: III. Role of B7 co-stimulation at priming.

Yang LP, Demeure CE, Byun DG, Vezzio N, Delespesse G.

Int Immunol. 1995 Dec;7(12):1987-93.

PMID:
8746568
32.

Default development of cloned human naive CD4 T cells into interleukin-4- and interleukin-5- producing effector cells.

Yang LP, Byun DG, Demeure CE, Vezzio N, Delespesse G.

Eur J Immunol. 1995 Dec;25(12):3517-20.

PMID:
8566047
33.

Human naive CD4 T cells produce interleukin-4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions.

Demeure CE, Yang LP, Byun DG, Ishihara H, Vezzio N, Delespesse G.

Eur J Immunol. 1995 Sep;25(9):2722-5.

PMID:
7589153
34.

In vitro maturation of neonatal human CD8 T lymphocytes into IL-4- and IL-5-producing cells.

Byun DG, Demeure CE, Yang LP, Shu U, Ishihara H, Vezzio N, Gately MK, Delespesse G.

J Immunol. 1994 Dec 1;153(11):4862-71.

PMID:
7963550
35.

Interleukin 12 exerts a differential effect on the maturation of neonatal and adult human CD45R0- CD4 T cells.

Shu U, Demeure CE, Byun DG, Podlaski F, Stern AS, Delespesse G.

J Clin Invest. 1994 Oct;94(4):1352-8.

36.

In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production.

Demeure CE, Wu CY, Shu U, Schneider PV, Heusser C, Yssel H, Delespesse G.

J Immunol. 1994 May 15;152(10):4775-82.

PMID:
7909823
37.

In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12.

Wu CY, Demeure CE, Gately M, Podlaski F, Yssel H, Kiniwa M, Delespesse G.

J Immunol. 1994 Feb 1;152(3):1141-53.

PMID:
7905497
38.

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ.

J Infect Dis. 1993 Oct;168(4):1000-8.

PMID:
7690821
39.

IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.

Wu CY, Demeure C, Kiniwa M, Gately M, Delespesse G.

J Immunol. 1993 Aug 15;151(4):1938-49.

PMID:
8102154
40.

Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis.

de Jesus AM, Almeida RP, Bacellar O, Araujo MI, Demeure C, Bina JC, Dessein AJ, Carvalho EM.

Eur J Immunol. 1993 Jan;23(1):152-8.

PMID:
8419165
41.
42.

Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni.

Dessein AJ, Couissinier P, Demeure C, Rihet P, Kohlstaedt S, Carneiro-Carvalho D, Ouattara M, Goudot-Crozel V, Dessein H, Bourgois A, et al.

Immunol Invest. 1992 Aug;21(5):423-53. Review.

PMID:
1428019
43.

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels.

Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ.

Eur J Immunol. 1991 Nov;21(11):2679-86.

PMID:
1936116
44.

Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen.

Dessein AJ, Begley M, Demeure C, Caillol D, Fueri J, dos Reis MG, Andrade ZA, Prata A, Bina JC.

J Immunol. 1988 Apr 15;140(8):2727-36.

PMID:
3128605
45.

Conformational differences of human IgE on hydrophobic and hydrophilic solid phases detected by monoclonal antibodies.

Anfosso F, Demeure C, Delaage M, Cheballah R, Bellot F, Bourgois A.

Mol Immunol. 1987 Nov;24(11):1129-34.

PMID:
2447490

Supplemental Content

Loading ...
Support Center